Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,965 | 11 | 51.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,880 | 10 | 42.0% |
| Travel and Lodging | $1,826 | 11 | 4.3% |
| Food and Beverage | $868.10 | 19 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $26,175 | 36 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $6,890 | 5 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $3,695 | 2 | $0 (2021) |
| Amneal Pharmaceuticals LLC | $2,600 | 1 | $0 (2022) |
| Genentech, Inc. | $1,695 | 1 | $0 (2020) |
| GW Pharma Limited | $1,250 | 1 | $0 (2020) |
| Celgene Corporation | $99.47 | 1 | $0 (2024) |
| Medtronic USA, Inc. | $73.83 | 1 | $0 (2017) |
| Penumbra, Inc. | $34.69 | 1 | $0 (2022) |
| TG Therapeutics, Inc. | $26.54 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,003 | 7 | E.R. Squibb & Sons, L.L.C. ($6,890) |
| 2023 | $13.37 | 1 | TG Therapeutics, Inc. ($13.37) |
| 2022 | $2,635 | 2 | Amneal Pharmaceuticals LLC ($2,600) |
| 2021 | $5,990 | 6 | Ipsen Biopharmaceuticals, Inc ($3,650) |
| 2020 | $3,785 | 3 | Genentech, Inc. ($1,695) |
| 2019 | $12,796 | 18 | Biogen, Inc. ($12,751) |
| 2018 | $10,244 | 13 | Biogen, Inc. ($10,244) |
| 2017 | $73.83 | 1 | Medtronic USA, Inc. ($73.83) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 09/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Immunology | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 07/09/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,640.00 | General |
| 03/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $99.47 | General |
| Category: Neuroscience | ||||||
| 05/30/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Immunology | ||||||
| 03/28/2022 | Amneal Pharmaceuticals LLC | LYVISPAH (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: NEUROLOGY | ||||||
| 01/19/2022 | Penumbra, Inc. | Real Immersive System (Device) | Food and Beverage | Cash or cash equivalent | $34.69 | General |
| Category: Neuro Rehabilitation | ||||||
| 12/08/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $360.00 | General |
| 11/03/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $360.00 | General |
| 07/26/2021 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Consulting Fee | Cash or cash equivalent | $3,650.00 | General |
| Category: Neurology | ||||||
| 06/15/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| 03/22/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| 03/16/2021 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| 06/27/2020 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,695.00 | General |
| 05/04/2020 | GW Pharma Limited | Epidiolex (Drug) | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| Category: Neurology | ||||||
| 01/27/2020 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 11/15/2019 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $44.93 | General |
| Category: Neurology | ||||||
| 11/04/2019 | Biogen, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| 11/04/2019 | Biogen, Inc. | — | Travel and Lodging | Cash or cash equivalent | $228.85 | General |
| 11/04/2019 | Biogen, Inc. | — | Travel and Lodging | Cash or cash equivalent | $123.40 | General |
| 11/04/2019 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $48.28 | General |
| 11/04/2019 | Biogen, Inc. | — | Travel and Lodging | Cash or cash equivalent | $7.50 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 216 | 403 | $175,062 | $20,600 |
| 2022 | 8 | 243 | 408 | $169,516 | $22,021 |
| 2021 | 7 | 257 | 460 | $180,744 | $25,534 |
| 2020 | 7 | 233 | 404 | $151,173 | $20,225 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2023 | 46 | 89 | $53,400 | $5,945 | 11.1% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2023 | 45 | 107 | $47,401 | $5,184 | 10.9% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2023 | 15 | 33 | $21,813 | $2,685 | 12.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 16 | 16 | $12,810 | $2,158 | 16.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 17 | 17 | $9,962 | $1,867 | 18.7% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 59 | 123 | $16,482 | $1,670 | 10.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 18 | 18 | $13,194 | $1,090 | 8.3% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Facility | 2022 | 42 | 86 | $46,870 | $5,725 | 12.2% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2022 | 39 | 88 | $35,464 | $4,287 | 12.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 43 | 43 | $28,638 | $3,290 | 11.5% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Facility | 2022 | 11 | 23 | $13,823 | $2,035 | 14.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $11,456 | $2,002 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 19 | $10,110 | $1,979 | 19.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2022 | 52 | 110 | $13,420 | $1,471 | 11.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 23 | $9,735 | $1,234 | 12.7% |
| 64642 | Injection of chemical for destruction of nerve muscles on one arm or leg, 1-4 muscles | Facility | 2021 | 49 | 108 | $58,860 | $8,128 | 13.8% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Facility | 2021 | 37 | 96 | $38,688 | $5,199 | 13.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 50 | 50 | $28,465 | $3,951 | 13.9% |
| 64644 | Injection of chemical for destruction of nerve muscles on one arm or leg, 5 or more muscles | Facility | 2021 | 13 | 27 | $16,227 | $2,526 | 15.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 35 | $13,355 | $2,016 | 15.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 19 | 19 | $9,899 | $1,872 | 18.9% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Facility | 2021 | 58 | 125 | $15,250 | $1,842 | 12.1% |
| 64642 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Facility | 2020 | 49 | 95 | $51,775 | $6,883 | 13.3% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Facility | 2020 | 38 | 78 | $31,434 | $3,966 | 12.6% |
| 64644 | Injection of chemical for destruction of nerve muscles on arm or leg, 5 or more muscles | Facility | 2020 | 15 | 33 | $19,833 | $2,766 | 13.9% |
About Dr. Francois Bethoux, MD
Dr. Francois Bethoux, MD is a Physical Medicine & Rehabilitation healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790727469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francois Bethoux, MD has received a total of $42,539 in payments from pharmaceutical and medical device companies, with $7,003 received in 2024. These payments were reported across 51 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($21,965).
As a Medicare-enrolled provider, Bethoux has provided services to 949 Medicare beneficiaries, totaling 1,675 services with total Medicare billing of $88,380. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Cleveland, OH
- Active Since 06/10/2006
- Last Updated 12/21/2007
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1790727469
Products in Payments
- DYSPORT (Drug) $3,695
- LYVISPAH (Drug) $2,600
- Epidiolex (Drug) $1,250
- ZEPOSIA (Drug) $99.47
- SYNCHROMED (Device) $73.83
- Real Immersive System (Device) $34.69
- BRIUMVI (Drug) $26.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Cleveland
John Chae, Md, Me, MD, ME
Physical Medicine & Rehabilitation — Payments: $29,915
Dr. Prudencio Balagtas, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $11,016
Dr. John Mccallin, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $7,806
Marzena Buzanowska, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $5,325
Michael Harris, Md, MD
Physical Medicine & Rehabilitation — Payments: $4,104
Dr. Edwin Capulong, Md, MD
Physical Medicine & Rehabilitation — Payments: $3,664